Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 2.7% beneficial ownership stake in Geospace Technologies Corporation as of June 30, 2025.

BlackRock, Inc. has disclosed a 6.5% beneficial ownership stake in Ginkgo Bioworks Holdings, Inc., holding over 3 million shares of common stock.

BlackRock, Inc. filed an Amendment No. 9 to its Schedule 13G, disclosing a 2.1% beneficial ownership stake in GoPro Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 14.4% in Grocery Outlet Holding Corp.'s common stock as of June 30, 2025.

BlackRock, Inc. has reported a beneficial ownership of 16.3% of Insteel Industries Inc.'s common stock, holding 3,172,177 shares as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.1% beneficial ownership stake in Inozyme Pharma Inc. as of June 30, 2025.

BlackRock, Inc. has reported a passive beneficial ownership of 5.6% of KULR Technology Group, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.5% passive beneficial ownership stake in LegalZoom.com Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G disclosing a 1.0% beneficial ownership in Lineage Cell Therapeutics Inc. common stock, while also noting that a subsidiary, BlackRock Institutional Trust Company, National Association, holds 5% or more.

BlackRock, Inc. has reported a 7.1% beneficial ownership stake in Magnera Corp's common stock as of June 30, 2025.

BlackRock, Inc. has reported an 11.1% beneficial ownership stake in Marriott Vacations Worldwide Corp. common stock as of June 30, 2025, holding 3,837,136 shares.

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, reporting beneficial ownership of 3.0% of Mersana Therapeutics Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, revealing a beneficial ownership of 13.2% of Capitol Federal Financial Inc.'s Common Stock.

BlackRock, Inc. has reported a 7.2% beneficial ownership stake in Clover Health Investments Corp. CLA, holding over 29.8 million shares as of June 30, 2025.

BlackRock, Inc. has reported a 5.8% beneficial ownership stake in Day One Biopharmaceuticals, Inc., holding 5,849,917 shares of common stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 1.6% beneficial ownership stake in Destination XL Group Inc. as of June 30, 2025.

BlackRock, Inc. has reported a 7.1% beneficial ownership stake in D-Wave Quantum Inc., holding 22,170,378 shares of common stock as of June 30, 2025, for investment purposes.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.8% beneficial ownership stake in EQT Corporation, representing 40,723,549 shares as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 5.5% beneficial ownership stake in Edgewise Therapeutics Inc., totaling 5,824,866 common shares.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.4% beneficial ownership stake in Eledon Pharmaceuticals, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.6% of Elevation Oncology, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has reported a 7.3% beneficial ownership stake in Emergent BioSolutions Inc., holding 3,977,535 shares of common stock as of June 30, 2025, for passive investment purposes.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 13.1% of Energizer Holdings Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a 14.5% beneficial ownership stake in Enpro Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.8% passive beneficial ownership stake in ESSA Bancorp, Inc. as of June 30, 2025.

BlackRock, Inc. has reported a 5.7% beneficial ownership stake in Eton Pharmaceuticals, Inc., holding 1,530,357 shares of common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a reduced beneficial ownership stake of 2.3% in Everspin Technologies Inc. common stock.

BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 4.3% beneficial ownership stake in Exact Sciences Corp. common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.9% beneficial ownership stake in FRP Holdings Inc. as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.3% of the common stock of Forge Global Holdings, Inc.